<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Pharmaceutical and Biomedical Research</title>
<title_fa></title_fa>
<short_title>Pharm Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://pbr.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-4486</journal_id_issn>
<journal_id_issn_online>2423-4494</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/pbr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>6</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Selenium Safeguards the Liver Against 5-Fluorouracil Induced Toxicity</title>
	<subject_fa>فارماکولوژی</subject_fa>
	<subject>Pharmacology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Background&lt;/strong&gt;: The hepatotoxic effect of 5-fluorouracil (5-FU) can deprive cancer patients of its maximum therapeutic benefits. Selenium (Se) is a trace element with potential benefits in some animal models of diseases.&lt;br&gt;
&lt;strong&gt;Objectives&lt;/strong&gt;: This study assessed the ability of Se to nullify the hepatotoxic effect of 5-FU in albino rats.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: In this study, 40 adult male albino rats were grouped into A to D (each 5 rats). Rats in group A (control) were treated intraperitoneally (IP) with normal saline (0.2 mL) daily for 5 days. Rats in groups B1 to B3 were treated IP with Se (0.125, 0.25, and 0.50 mg/kg) daily for 5 days, respectively. Rats in group C were treated IP with 5-FU (20 mg/kg) daily for 5 days. Rats in groups D1to D3 were treated IP with Se with 0.125, 0.25, and 0.50 mg/kg before treatment with 5-FU (20 mg/kg) daily for 5 days, respectively. After treatment, the rats were euthanized, and their blood samples were collected and evaluated for serum liver function. Liver samples were evaluated for biochemical and histological parameters.&lt;br&gt;
&lt;strong&gt;Results&lt;/strong&gt;: Liver and serum aminotransferases, gamma-glutamyl transferase, lactate dehydrogenase, alkaline phosphatase, total bilirubin, and conjugated bilirubin levels were significantly (P&lt;0.001) high in 5-FU-treated rats in comparison to the control group. Liver glutathione peroxidase, superoxide dismutase (SOD), catalase, and glutathione levels were significantly (P&lt;0.001) low whereas the malondialdehyde level was significantly (P&lt;0.001) high in 5-FU-treated rats compared with the control group. Moreover, hepatocyte necrosis was observed in 5-FU-treated rats.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Conclusion&lt;/strong&gt;: Nonetheless, 5-FU-induced hepatotoxicity was significantly nullified in rats supplemented with Se (0.125 mg/kg, P&lt;0.05; 0.25 mg/kg, P&lt;0.01, and 0.5 mg/kg, P&lt;0.001) in a dose-dependent fashion in comparison to 5-FU-treated rats. Thus, Se may have a clinical benefit in 5-FU-induced hepatotoxicity</abstract>
	<keyword_fa></keyword_fa>
	<keyword>5-Fluorouracil, Liver chemotherapy, Toxicity, Selenium, Protection, Antioxidant</keyword>
	<start_page>197</start_page>
	<end_page>204</end_page>
	<web_url>http://pbr.mazums.ac.ir/browse.php?a_code=A-10-744-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Elias</first_name>
	<middle_name></middle_name>
	<last_name>Adikwu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>adikwuelias@gmail.com</email>
	<code>10031947532846005844</code>
	<orcid>10031947532846005844</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Niger Delta University, Amassama, Nigeria.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Nelson</first_name>
	<middle_name></middle_name>
	<last_name>Clemente Ebinyo</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>adikwuelias@yahoo.com</email>
	<code>10031947532846005845</code>
	<orcid>10031947532846005845</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Niger Delta University, Amassama, Nigeria.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
